Magnetic resonance parameter | Baseline No treatment | 6 Months No treatment | Baseline -ASA | 6 Months + ASA |
---|---|---|---|---|
Structural features | ||||
PDFF (%) mean ± SD | 37 ± 22 | 40 ± 23 | 47 ± 23 | 43 ± 20 |
ADC (10–3 mm2 / s) mean ± SD | 1.39 ± 0.41 | 1.28 ± 0.43 | 1.40 ± 0.37 | 1.38 ± 0.39 |
ADC Kurtosis (-) mean ± SD | 3.38 ± 1.54 | 3.03 ± 0.99 | 3.01 ± 0.99 | 3.00 ± 0.61 |
Dynamic characteristics | ||||
Perfusion, AUC (a.u.) mean ± SD | 29 ± 20 | 26 ± 23 | 30 ± 21 | 25 ± 17 |
Perfusion, tau (s) | 68 ± 23 | 70 ± 33 | 69 ± 30 | 73 ± 25 |
R1 (s−1; fibroglandular, whole breast) | 2.0 ± 0.2 | 2.0 ± 0.2 | 2.0 ± 0.2 | 2.0 ± 0.3 |
R2 (s−1; fibroglandular, whole breast) | 13.6 ± 0.5 | 13.5 ± 0.5 | 13.7 ± 0.5 | 13.4 ± 0.4* |
PD (%; fibroglandular, whole breast) | 84 ± 4 | 84 ± 3.9 | 85 ± 3.4 | 85 ± 3.5 |